• Early and accurate diagnosis of tuberculosis (TB) and treatment are the mainstay of TB control. Smear microscopy, a sole diagnostic tool in resource limited settings, has low sensitivity particularly in settings with HIV burden. 
INTRODUCTION
• Early and accurate diagnosis of tuberculosis (TB) and treatment are the mainstay of TB control. Smear microscopy, a sole diagnostic tool in resource limited settings, has low sensitivity particularly in settings with HIV burden.
• Nucleic acid amplification tests (NAATs) for TB are highperforming tests for detecting TB RNA and DNA in clinical samples.
• The EasyNAT TM tuberculosis isothermal nucleic acid amplification diagnostic kit by Ustar Biotechnologies Co., Ltd. uses isothermal cross-priming amplification technology for the qualitative detection of Mycobacterium tuberculosis (M. tuberculosis).
OBJECTIVE
• To evaluate the diagnostic performance of EasyNAT in detecting M. tuberculosis from sputum smears of presumptive pulmonary TB patients in Bagamoyo, Tanzania
METHODS
• From a TB cohort study of presumptive TB patients, one ml of frozen fresh untreated morning or spot sputum samples was used to evaluate EasyNAT against Ziehl Nielsen (ZN) smear microscopy, BACTEC Mycobacterium Growth Indicator Tube (MGIT) 960 and Löwenstein Jensen (LJ) culture. • Molecular genotyping (Genotype MTBC, CM or AS; Hain Lifescience, Nehren) and MPT64 antigen confirmed M. tuberculosis or non-tuberculous mycobacteria.
RESULTS
• We analyzed sputum samples of 143 presumptive TB patients ( Figure 1 
CONCLUSION
• The EasyNAT assay detected M. tuberculosis with an excellent specificity and positive predictive value. The sensitivity was acceptable in the smear-positive patients.
• However, the low detection rate for the smear-negative, culturepositive sputum samples might be a limitation for wider clinical use and requires further evaluation in larger study populations from different regions that are endemic for TB. 
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